| Literature DB >> 23347703 |
Joshua O Yukich1, Cameron Taylor, Thomas P Eisele, Richard Reithinger, Honelgn Nauhassenay, Yemane Berhane, Joseph Keating.
Abstract
BACKGROUND: Malaria remains the leading communicable disease in Ethiopia, with around one million clinical cases of malaria reported annually. The country currently has plans for elimination for specific geographic areas of the country. Human movement may lead to the maintenance of reservoirs of infection, complicating attempts to eliminate malaria.Entities:
Mesh:
Year: 2013 PMID: 23347703 PMCID: PMC3570338 DOI: 10.1186/1475-2875-12-33
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Location of the study site – Bulbulla Health Centre, Adami Tulu Wereda, Oromia Regional State, Ethiopia.
Basic description of the study sample
| | |||||
|---|---|---|---|---|---|
| | | | | | |
| Female | 39 (45.9) | 22 (38.6)** | 60 (42.6)** | 247 (59.4) | 307 (54.8) |
| Missing | 0 (0.0) | 0 (0.0)** | 0 (0.0)** | 3 (0.7) | 3 (0.5) |
| | | | | | |
| 18-20 | 26 (30.6) | 24 (42.1) | 50 (35.5) | 116 (27.7) | 166 (29.6) |
| 21-25 | 17 (20.0) | 12 (21.1) | 29 (20.6) | 80 (19.1) | 109 (19.5) |
| 26-32 | 16 (18.8) | 11 (19.3) | 27 (19.2) | 113 (27.0) | 140 (25.0) |
| 33+ | 23 (27.1) | 9 (15.8) | 31 (22.0) | 100 (23.9) | 131 (23.4) |
| Missing | 3 (3.5) | 1 (1.8) | 4 (2.84) | 10 (2.4) | 14 (2.5) |
| | | | | | |
| Agriculture | 62 (72.9) | 38 (66.7) | 99 (70.2) | 301 (71.8) | 400 (71.4) |
| Non-Agricultural | 23 (27.1) | 19 (33.3) | 42 (29.8) | 116 (27.7) | 158 (28.2) |
| Missing | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.5) | 2 (0.4) |
| | | | | | |
| Yes | 76 (89.4) | 47 (82.5) | 122 (86.5) | 365 (87.1) | 487 (87.0) |
| | | | | | |
| Thatch/Leaf | 53 (62.4)* | 27 (47.4) | 79 (56.0) | 206 (49.2) | 285 (50.9) |
| Corrugated Iron | 31 (36.5)* | 30 (52.6) | 61 (43.3) | 205 (48.9) | 266 (47.5) |
| Other | 1 (1.2)* | 0 (0.0) | 1 (0.7) | 8 (1.9) | 9 (1.6) |
| | | | | | |
| Bamboo/Wood | 28 (32.9) | 19 (33.3)** | 47 (33.3)* | 140 (33.4) | 187 (33.4) |
| Covered Adobe | 38 (44.7) | 15 (26.3)** | 53 (37.6)* | 200 (47.7) | 253 (45.2) |
| Wood Planks/Shingles | 12 (14.1) | 13 (22.8)** | 24 (17.0)* | 44 (10.5) | 68 (12.1) |
| Other | 7 (8.2) | 10 (17.5)** | 17 (12.0)* | 33 (7.9) | 50 (8.9) |
| Missing | 0 (0.0) | 0 (0.0)** | 0 (0.0)* | 2 (0.5) | 2 (0.4) |
| | | | | | |
| Yes | 15 (17.7) | 17 (29.9) | 32 (22.7) | 95 (22.7) | 127 (22.7) |
| Missing | 1 (1.2) | 0 (0.0) | 1 (0.7) | 3 (0.7) | 4 (0.7) |
| | | | | | |
| Yes | 29 (34.1) | 21 (36.8) | 50 (35.5)* | 190 (45.4) | 240 (42.9) |
| Missing | 1 (1.2) | 1 (1.8) | 2 (1.4)* | 4 (1.0) | 6 (1.1) |
| | | | | | |
| Yes | 36 (42.4) | 21 (36.8) | 57 (40.4) | 136 (32.5) | 193 (34.5) |
| Missing | 0 (0.0) | 1 (1.8) | 1 (0.7) | 6 (1.4) | 7 (1.3) |
| | | | | | |
| Yes | 34 (40.0) | 19 (33.3) | 53 (37.6) | 181 (43.2) | 234 (41.8) |
| Missing | 1 (1.2) | 0 (0.0) | 1 (0.7) | 6 (1.4) | 7 (1.3) |
| Yes | 14 (16.5) | 12 (21.1) | 26 (18.4) | 82 (19.6) | 108 (19.3) |
| Missing | 1 (1.2) | 1 (1.8) | 2 (1.4) | 9 (2.2) | 11 (2.0) |
§P.f.+ and P.v.+ totals include mixed diagnosis; **Significant difference between cases and controls at the 5% level, using a χ2 (Fischer’s Exact) test. *Significant difference between cases and controls at the 10% level using a χ2 (Fischer’s Exact) test.
Adjusted odds ratios from logistic regression models
| | ||||||
|---|---|---|---|---|---|---|
| 1.763** | 0.030 | 1.17 | 0.618 | 1.64** | 0.024 | |
| (1.06-2.93) | | (0.63-2.16) | | (1.07-2.52) | | |
| - | - | - | - | - | - | |
| (2) | 0.72 | 0.329 | 1.47 | 0.386 | 0.97 | 0.904 |
| (0.38-1.39) | | (0.61-3.52) | | (0.54-1.71) | | |
| (3) | 0.46** | 0.029 | 1.09 | 0.846 | 0.60* | 0.098 |
| (0.23-0.92) | | (0.45-2.66) | | (0.33-1.10) | | |
| 0.36** | 0.008 | 1.26 | 0.609 | 0.57* | 0.067 | |
| (0.17-0.76) | | (0.52-3.02) | | (0.31-1.03) | | |
| 18-20 | - | - | - | - | - | - |
| 21-25 | 1.12 | 0.751 | 0.66 | 0.289 | 0.85 | 0.581 |
| (0.56-2.24) | | (0.30-1.43) | | (0.48-1.51) | | |
| 26-32 | 0.69 | 0.299 | 0.45** | 0.050 | 0.51** | 0.021 |
| (0.34-1.39) | | (0.21-1.00) | | (0.29-0.90) | | |
| 32+ | 0.94 | 0.854 | 0.27** | 0.006 | 0.49** | 0.018 |
| (0.48-1.84) | | (0.10-0.68) | | (0.27-0.89) | | |
| Female | - | - | - | - | - | - |
| Male | 1.62* | 0.065 | 2.01** | 0.025 | 2.00** | 0.001 |
| (0.97-2.70) | | (1.09-3.71) | | (1.31-3.06) | | |
| 0.89 | 0.732 | 1.32 | 0.455 | 1.09 | 0.752 | |
| (0.45-1.75) | (0.64-2.75) | (0.64-1.87) | ||||
§P.f.+ and P.v.+ totals include mixed diagnosis; **Significant difference between cases and controls at the 5% level. *Significant difference between cases and controls at the 10% level.